Hudson Bay Capital Management
LEGN icon

Hudson Bay Capital Management’s Legend Biotech LEGN Stock Holding History

Hudson Bay Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-150,200
Closed -$2.72M – 1541
2026
Q1 		$2.72M Buy
+150,200
New +$2.86M 0.01% 682

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Hudson Bay Capital Management's LEGN Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Legend Biotech (LEGN) stake by 61% in Q2 2026, selling an estimated $14.5M and leaving 340,000 shares worth $9.82M. The position accounts for 0.03% of the portfolio, ranked #375.

Hudson Bay Capital Management first reported a position in LEGN in Q2 2020 and has held it in 19 quarters since. The position peaked at $122M in Q2 2020. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Hudson Bay Capital Management held 340,000 shares of Legend Biotech worth $9.82M as of Q2 2026.
  • Hudson Bay Capital Management sold 536,351 Legend Biotech shares in Q2 2026, an estimated $14.5M.
  • Legend Biotech made up 0.03% of Hudson Bay Capital Management's portfolio in Q2 2026, its #375 holding.
  • Hudson Bay Capital Management first reported a position in Legend Biotech in Q2 2020 and has held it in 19 quarters since.
  • Hudson Bay Capital Management's Legend Biotech position peaked at $122M in Q2 2020.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.